Moderna stock tanks on COVID vaccine delivery slowdown Due to the delays and prioritization of low-income countries, Moderna anticipates fiscal year 2021 product sales between $15B and $18B, down from previous guidance of $20 billion. https://ift.tt/G6b7xOm https://ift.tt/8axrzMI Markets November 4, 2021 at 07:59PM
إرسال تعليق